Yıl: 2021 Cilt: 31 Sayı: 1 Sayfa Aralığı: 80 - 83 Metin Dili: İngilizce DOI: 10.5222/terh.2021.93798 İndeks Tarihi: 26-11-2021

A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio

Öz:
Amaç: Hepatosteatosis (HS) is defined as accumulation of fat in liver reaching to an amount of at least 5% of liverweight. Not just mean platelet volume (MPV), but also MPV to lymphocyte ratio (MPVLR) has been introduced asa marker in inflammatory and metabolic conditions. We aimed to compare MPVLR values of patients with hepa tosteatosis with those of healthy controls. We also investigated the correlation between CRP and MPVLRMethods: The data of the patients with HS who were admitted to internal medicine outpatient clinics of our insti tution between 2018 December and 2019 December were enrolled into the study. The MPVLR were calculatedusing MPV/lymphocyte formula. Results: The median MPVLRs of the HS and control groups were 4.3% (2.1) and 3.6% (1.7), respectively (p<0.001).The median CRP levels of the HS and control groups were 3.6 (4.9) mg/L and 0.4 (0.2) mg/L, respectively (p<0.001).The MPVLR was positively and strongly correlated with CRP (r=0.64, p<0.001). However, MPVLR and the biochemi cal parameters; LDL-cholesterol, ALT and triglyceride were not correlated at all.. Conclusion: We suggest that elevated MPVLR should alert physicians for possible hepatosteatosis in a populationwithout comorbidities. Positive and strong correlation between CRP and MPVLR should also prompt use of MPVLRas a reliable inflammatory predictor.
Anahtar Kelime:

Hepatosteatozda Yeni Bir Laboratuvar Belirteci: Ortalama Trombosit Hacmi/Lenfosit Oranı

Öz:
Objective: Hepatosteatoz (HS), karaciğerde en az %5 kuru ağırlığa denk gelecek şekilde yağ birikmesidir. SadeceOrtalama trombosit hacmi (MPV) değil, aynı zamanda ortalama trombosit hacmi/lenfosit oranı (MPVLR) metabo lik ve enflamatuvar durumların bir belirteci olarak bildirilmektedir. Bu çalışmamızda hepatosteatozlu hastalarınMPVLR değerini, sağlıklı kontrol grubuyla karşılaştırmayı amaçladık. Ayrıca CRP ile MPVLR arasındaki korelasyonuaraştırdık. Yöntem: Kurumumuz iç hastalıkları polikliniklerine 2018 Aralık-2019 Aralık tarihleri arasında başvuran HS’lu hasta lar çalışmaya alındı. MPVLR, MPV/Lenfosit formülü ile hesaplandı. Bulgular: HS ve kontrol gruplarının medyan MPVLR değeri sırasıyla %4.3 (2.1) ve %3.6 (1.7) idi (p<0.001). HS vekontrol gruplarının medyan CRP değeri sırasıyla 3.6 (4.9) mg/L ve 0.4 (0.2) mg/L idi (p<0.001). MPVLR, CRP ilepozitif ve güçlü bir korelasyona sahipti (r=0.64, p<0.001). Buna karşın, MPVLR ile LDL kolesterol, ALT ve trigliseritarasında korelasyon yoktu.Sonuç: Komorbiditesi bulunmayan HS’lu hastalarda artmış MPVLR değeri, hekimler için HS açısından uyarıcıolmalıdır. CRP ile MPVLR arasındaki güçlü pozitif korelasyon, MPVLR’nin de güvenilir bir inflamatuvar belirteçolduğunu düşündürmektedir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Nassir F, Rector RS, Hammoud GM, Ibdah JA. Pathogenesis and Prevention of Hepatic Steatosis. Gastroenterology & Hepatology. 2015;11:167-75.
  • 2. Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflammatory Bowel Diseases. 2004;10:661-5. [CrossRef]
  • 3. Sit M, Aktas G, Yilmaz EE, Hakyemez IN, Alcelik A, Kucukbayrak A. Platelet parameters in hepatic hydatid cysts. International Journal of Inflammation. 2013;2013:593273. [CrossRef]
  • 4. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. The American Journal of Gastroenterology 2001;96:776-81. [CrossRef]
  • 5. Aktas G, Cakiroglu B, Sit M, et al. Mean platelet volume: a simple indicator of chronic prostatitis. Acta Medica Mediterranea. 2013;29:551-4.
  • 6. Ulasli SS, Ozyurek BA, Yilmaz EB, Ulubay G. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Polskie Archiwum Medycyny Wewnetrznej. 2012;122:284-90. [CrossRef]
  • 7. Aktas G, Sit M, Tekce H, et al. Mean platelet volume in nasal polyps. The West Indian Medical Journal. 2013;62:515-8. [CrossRef]
  • 8. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. Journal of thrombosis and haemostasis: JTH. 2010;8:148-56. [CrossRef]
  • 9. Cakir L, Aktas G, Enginyurt O, Cakir SA. Mean platelet volume increases in type 2 diabetes mellitus independent of HbA1c level. Acta Medica Mediterranea. 2014;30:425-8.
  • 10. Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KM, Kitas GD. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflammation & Allergy Drug Targets. 2010;9:45-50. [CrossRef]
  • 11. Aktas G, Alcelik A, Tekce BK, Tekelioglu V, Sit M, Savli H. Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome. Przeglad Gastroenterologiczny. 2014;9:160-3. [CrossRef]
  • 12. Jaremo P, Sandberg-Gertzen H. Platelet density and size in inflammatory bowel disease. Thrombosis and Haemostasis. 1996;75:560-1. [CrossRef]
  • 13. Cakir L, Aktas G, Mercimek OB, Enginyurt O, Kaya Y, Mercimek K. Are red cell distribution width and mean platelet volume associated with rheumatoid arthritis? 2016.
  • 14. Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. International Journal of Clinical Practice. 2009;63:1509-15. [CrossRef]
  • 15. Aktas G, Kocak MZ, Duman TT, et al. Mean Platelet Volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity. Bali Medical Journal. 2018;7:650-3. [CrossRef]
  • 16. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Current Pharmaceutical Design. 2011;17:47-58. [CrossRef]
  • 17. Kocak MZ, Aktas G, Erkus E, Duman TT, Atak BM, Savli H. Mean Platelet Volume to Lymphocyte Ratio as a Novel Marker for Diabetic Nephropathy. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP. 2018;28:844-7. [CrossRef]
  • 18. Bozlu G, Akar A, Durak F, Kuyucu N. Role of mean platelet volume-to-lymphocyte ratio in the diagnosis of childhood appendicitis. Archivos Argentinos de Pediatria. 2019;117:375- 80. [CrossRef]
  • 19. Bilgin S, Aktas G, Zahid Kocak M, et al. Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men. The aging male : the official journal of the International Society for the Study of the Aging Male. 2019:1-5. [CrossRef]
  • 20. Hudzik B, Szkodzinski J, Lekston A, Gierlotka M, Polonski L, Gasior M. Mean platelet volume-to-lymphocyte ratio: a novel marker of poor short- and long-term prognosis in patients with diabetes mellitus and acute myocardial infarction. Journal of Diabetes and Its Complications. 2016;30:1097- 102. [CrossRef]
  • 21. Watanabe Y, Kawada M, Kobayashi B. Effect of insulin on murine megakaryocytopoiesis in a liquid culture system. Cell Structure and Function. 1987;12:311-6. [CrossRef]
APA BİLGEN S, Kurtkulagi O (2021). A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. , 80 - 83. 10.5222/terh.2021.93798
Chicago BİLGEN Satılmış,Kurtkulagi Ozge A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. (2021): 80 - 83. 10.5222/terh.2021.93798
MLA BİLGEN Satılmış,Kurtkulagi Ozge A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. , 2021, ss.80 - 83. 10.5222/terh.2021.93798
AMA BİLGEN S,Kurtkulagi O A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. . 2021; 80 - 83. 10.5222/terh.2021.93798
Vancouver BİLGEN S,Kurtkulagi O A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. . 2021; 80 - 83. 10.5222/terh.2021.93798
IEEE BİLGEN S,Kurtkulagi O "A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio." , ss.80 - 83, 2021. 10.5222/terh.2021.93798
ISNAD BİLGEN, Satılmış - Kurtkulagi, Ozge. "A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio". (2021), 80-83. https://doi.org/10.5222/terh.2021.93798
APA BİLGEN S, Kurtkulagi O (2021). A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. İzmir Tepecik Eğitim Hastanesi Dergisi, 31(1), 80 - 83. 10.5222/terh.2021.93798
Chicago BİLGEN Satılmış,Kurtkulagi Ozge A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. İzmir Tepecik Eğitim Hastanesi Dergisi 31, no.1 (2021): 80 - 83. 10.5222/terh.2021.93798
MLA BİLGEN Satılmış,Kurtkulagi Ozge A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. İzmir Tepecik Eğitim Hastanesi Dergisi, vol.31, no.1, 2021, ss.80 - 83. 10.5222/terh.2021.93798
AMA BİLGEN S,Kurtkulagi O A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. İzmir Tepecik Eğitim Hastanesi Dergisi. 2021; 31(1): 80 - 83. 10.5222/terh.2021.93798
Vancouver BİLGEN S,Kurtkulagi O A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio. İzmir Tepecik Eğitim Hastanesi Dergisi. 2021; 31(1): 80 - 83. 10.5222/terh.2021.93798
IEEE BİLGEN S,Kurtkulagi O "A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio." İzmir Tepecik Eğitim Hastanesi Dergisi, 31, ss.80 - 83, 2021. 10.5222/terh.2021.93798
ISNAD BİLGEN, Satılmış - Kurtkulagi, Ozge. "A Novel Laboratory Marker for Hepatosteatosis:Mean Platelet Volume to Lymphocyte Count Ratio". İzmir Tepecik Eğitim Hastanesi Dergisi 31/1 (2021), 80-83. https://doi.org/10.5222/terh.2021.93798